Protagonist Therapeutics, Inc. (PTGX)
NASDAQ: PTGX · Real-Time Price · USD
96.66
+4.57 (4.96%)
Mar 9, 2026, 4:00 PM EDT - Market closed
Protagonist Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 6,168 | 5,460 | 2,300 | 1,323 | 537 | 1,632 | Upgrade
|
| Market Cap Growth | 168.88% | 137.35% | 73.94% | 146.40% | -67.12% | 88.22% | Upgrade
|
| Enterprise Value | 5,532 | 4,792 | 1,728 | 1,002 | 274 | 1,286 | Upgrade
|
| Last Close Price | 96.66 | 87.34 | 38.60 | 22.93 | 10.91 | 34.20 | Upgrade
|
| PE Ratio | - | - | 8.36 | - | - | - | Upgrade
|
| Forward PE | 32.35 | 59.76 | - | - | - | - | Upgrade
|
| PS Ratio | 134.03 | 118.66 | 5.30 | 22.04 | 20.19 | 59.67 | Upgrade
|
| PB Ratio | 9.84 | 8.88 | 3.41 | 3.93 | 2.49 | 5.44 | Upgrade
|
| P/TBV Ratio | 10.03 | 8.88 | 3.41 | 3.93 | 2.49 | 5.44 | Upgrade
|
| P/FCF Ratio | 109.98 | 97.36 | 12.59 | - | - | - | Upgrade
|
| P/OCF Ratio | 106.95 | 94.68 | 12.49 | - | - | - | Upgrade
|
| EV/Sales Ratio | 120.22 | 104.14 | 3.98 | 16.69 | 10.29 | 47.01 | Upgrade
|
| EV/EBITDA Ratio | - | - | 6.81 | - | - | - | Upgrade
|
| EV/EBIT Ratio | - | - | 6.84 | - | - | - | Upgrade
|
| EV/FCF Ratio | 98.64 | 85.45 | 9.45 | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.02 | 0.02 | 0.02 | 0.00 | 0.02 | 0.02 | Upgrade
|
| Debt / EBITDA Ratio | - | - | 0.04 | - | - | - | Upgrade
|
| Debt / FCF Ratio | 0.18 | 0.18 | 0.06 | - | - | - | Upgrade
|
| Net Debt / Equity Ratio | -1.03 | -1.03 | -0.81 | -1.01 | -1.08 | -1.07 | Upgrade
|
| Net Debt / EBITDA Ratio | 4.05 | 4.05 | -2.16 | 3.67 | 1.79 | 2.57 | Upgrade
|
| Net Debt / FCF Ratio | -11.33 | -11.33 | -3.00 | 4.81 | 2.15 | 2.95 | Upgrade
|
| Asset Turnover | 0.07 | 0.07 | 0.79 | 0.20 | 0.09 | 0.08 | Upgrade
|
| Quick Ratio | 12.59 | 12.59 | 12.39 | 16.54 | 7.61 | 7.55 | Upgrade
|
| Current Ratio | 12.71 | 12.71 | 12.48 | 16.71 | 7.80 | 7.74 | Upgrade
|
| Return on Equity (ROE) | -20.18% | -20.18% | 54.39% | -28.59% | -49.41% | -43.32% | Upgrade
|
| Return on Assets (ROA) | -13.99% | -13.99% | 28.66% | -19.32% | -27.57% | -23.40% | Upgrade
|
| Return on Invested Capital (ROIC) | -229.61% | -97.34% | 189.05% | - | - | - | Upgrade
|
| Return on Capital Employed (ROCE) | -25.40% | -25.40% | 36.30% | -27.80% | -60.60% | -41.40% | Upgrade
|
| Earnings Yield | -2.11% | -2.38% | 11.96% | -5.97% | -23.73% | -7.69% | Upgrade
|
| FCF Yield | 0.91% | 1.03% | 7.95% | -5.36% | -20.29% | -6.68% | Upgrade
|
| Buyback Yield / Dilution | 2.31% | 2.31% | -14.65% | -15.74% | -5.87% | -34.67% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.